Aurora, CO, United States of America

Rinku Baid

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Colorado. Active years: 2016-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rinku Baid. Retrieved from https://idiyas.com/inventor/rinku-baid

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rinku Baid: Innovator in Degenerative Disorder Treatments

Introduction

Rinku Baid is a notable inventor based in Aurora, CO (US). She has made significant contributions to the field of medical science, particularly in the treatment of degenerative disorders. With a focus on innovative peptide formulations, her work aims to address critical health challenges.

Latest Patents

Rinku Baid holds 2 patents related to LEDGF peptides and their formulations for the treatment of degenerative disorders. These patents detail LEDGF peptides with anti-protein aggregation activity and methods of use. The disclosed LEDGF peptides demonstrate the ability to treat degenerative diseases and conditions associated with various cellular stresses, including oxidative stress and protein-aggregation stress. Additionally, her patents include extended release formulations, some of which are suitable for ophthalmic administration.

Career Highlights

Rinku Baid is affiliated with the University of Colorado, where she continues her research and development efforts. Her work is pivotal in advancing therapeutic options for patients suffering from degenerative diseases.

Collaborations

Rinku collaborates with esteemed colleagues, including Arun K Upadhyay and Sarath Yandrapu, to further enhance her research initiatives.

Conclusion

Rinku Baid's innovative work in the field of peptide formulations represents a significant advancement in the treatment of degenerative disorders. Her contributions are poised to make a lasting impact on medical science and patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…